News

November 15, 2010

An international collaboration between UC Santa Barbara, the Keck School of Medicine of the University of Southern California (USC), and several other research institutions, is bringing together leaders in the fields of stem cell biology, basic science, and ophthalmology to develop a treatment for blindness caused by age-related macular degeneration.

Related Links

October 28, 2009

The California Institute for Regenerative Medicine (CIRM) and UK Medical Research Council (MRC) are funding a $20 million multi-institutional grant on vision research. UC Santa Barbara will receive $2.5 million for their stem cell-related research. This funding will help translate basic stem cell research to clinical trials on treating macular degeneration.

Related Links

June 11, 2009

Age-related macular degeneration and other eye diseases are possible candidates for future stem cell therapies. Researchers from UC Santa Barbara’s Center for Stem Cell Biology and Engineering and Center for the Treatment of Macular Degeneration are collaborating with the Doheny Eye Institute and the London Project to Cure Blindness at the University College London to generate ocular cells from stem cells. A recent article in Nature discusses ongoing efforts to develop stem cell therapies for the eye.

Related Links

January 30, 2009

UC Santa Barbara has received a $1.2 million training grant from the California Institute for Regenerative Medicine (CIRM) to continue an interdisciplinary training program in stem cell biology and engineering. The three-year grant will make it possible for pre-doctoral and postdoctoral students to participate in groundbreaking research in two broad but interrelated areas: the fundamental molecular biology of stem cell proliferation and differentiation, and bioengineering approaches to develop novel biotechnologies for stem cell research.

Related Links

December 15, 2008

UC Santa Barbara was awarded over half a million dollars from the California Institute for Regenerative Medicine (CIRM) to support an interdisciplinary investigation to develop novel, as well as build upon existing, stem cell tools and technologies that will help provide a foundation for future clinical applications.

Related Links

October 03, 2008

UCSB stem cell researchers, working with Minerva Biotechnologies, recently reported that a cleaved form of MUC1, a transmembrane mucin protein aberrantly expressed in most solid human tumors, acts as a growth factor receptor on undifferentiated human embryonic stem cells. Lead author Sherry Hikita and coworkers show that activation of MUC1* stimulates growth of hESC and therefore may prove useful in culture and maintenence of hESC cell lines.

Related Links

September 23, 2008

The UCSB Center for Stem Cell Biology and Engineering Co-Directors and other UCSB stem cell researchers discuss the promise of, as well as problems with, using stem cells for regenerative medicine in this Convergence issue, which also features a separate, in-depth interview with Co-Director Prof. Dennis Clegg.

Related Links

May 07, 2008

UC Santa Barbara has been awarded $3.2 million from the California Institute for Regenerative Medicine (CIRM) in support of the development of a state-of-the-art facility in the newly established Center for Stem Cell Biology and Engineering at UCSB.

Related Links

November 29, 2007

These articles are on the establishment of the Southern California Stem Cell Scientific Collaboration (SC3), which includes UCSB and five other affiliates.

Related Links

Pages